(Press-News.org) Millions of people in the United States have a circulatory problem of the legs called peripheral vascular disease. It can be painful and may even require surgery in serious cases. This disease can lead to severe skeletal muscle wasting and, in turn, limb amputation.
At The University of Texas Health Science Center at Houston (UTHealth) Medical School, scientists tested a non-surgical preventative treatment in a mouse model of the disease and it was associated with increased blood circulation. Their proof-of-concept study appears in the journal Cell Reports.
Unlike previous studies in which other investigators used individual stimulatory factors to grow blood vessels, Vihang Narkar, Ph.D., senior author and assistant professor in the Department of Integrative Biology and Pharmacology at the UTHealth Medical School, identified and turned off a genetic switch that stifles blood vessel development.
"We discovered an inhibitory switch that degrades blood vessels," said Narkar, whose laboratory is in the UTHealth Center for Metabolic and Degenerative Diseases at The Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases. "We were able to genetically turn it off to prevent peripheral vascular disease in a preclinical study."
Added Narkar, "Our next step will be to test this targeted treatment in models of other conditions that dramatically decrease circulation like diabetes and atherosclerosis."
Narkar said using individual growth factors to stimulate blood vessel growth often leads to the formation of leaky and non-functional blood vessels. "By turning off a genetic switch that acts as a roadblock for blood vessel growth, we were able to trigger and accelerate the natural process of blood vessel regeneration that involves a battery of growth factors," he said.
The switch is called peroxisome proliferator-activated receptor gamma co-activator 1 beta (PGC1beta) and could be a key to future treatments for additional conditions like cardiac myopathies, cancer and retinopathy.
INFORMATION:
Narkar's UTHealth co-authors are Vikas Yadav, Ph.D. (lead author), Antonios Matsakas, Ph.D., and Sabina Lorca. Narkar is on the faculty of The University of Texas Graduate School of Biomedical Sciences at Houston.
The study titled "PGC1beta activates anti-angiogenic program to repress neo-angiogenesis in muscle ischemia" received support from the American Heart Association (AHA#11SDG7600213), American Diabetes Association (ADA#1-13-BS-127) and Muscular Dystrophy Association (MDA#174408).
Scientists discover genetic switch that can prevent peripheral vascular disease in mice
2014-07-28
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Mineral magic? Common mineral capable of making and breaking bonds
2014-07-28
TEMPE, Ariz. - Reactions among minerals and organic compounds in hydrothermal environments are critical components of the Earth's deep carbon cycle, they provide energy for the deep biosphere, and may have implications for the origins of life. However, very little is known about how minerals influence organic reactions. A team of researchers from Arizona State University have demonstrated how a common mineral acts as a catalysts for specific hydrothermal organic reactions – negating the need for toxic solvents or expensive reagents.
At the heart of organic chemistry, ...
Forced mutations doom HIV
2014-07-28
CAMBRIDGE, MA -- Fifteen years ago, MIT professor John Essigmann and colleagues from the University of Washington had a novel idea for an HIV drug. They thought if they could induce the virus to mutate uncontrollably, they could force it to weaken and eventually die out — a strategy that our immune system uses against many viruses.
The researchers developed such a drug, which caused HIV to mutate at an enhanced rate, as expected. But it did not eliminate the virus from patients in a small clinical trial reported in 2011. In a new study, however, Essigmann and colleagues ...
Tennessee Surgical Quality Collaborative saves 533 lives and $75 million in 3 years
2014-07-28
NEW YORK (July 28, 2:45 pm [ET]): Ten hospitals in the Tennessee Surgical Quality Collaborative (TSQC) have reduced surgical complications by 19.7 percent since 2009, resulting in at least 533 lives saved and $75.2 million in reduced costs, according to new results presented today at the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) National Conference in New York City.
The hospital collaborative was formed in 2008 as a partnership of the Tennessee Chapter of the American College of Surgeons and the Tennessee Hospital Association's ...
Stimulation of brain region restores consciousness to animals under general anesthesia
2014-07-28
Stimulating one of two dopamine-producing regions in the brain was able to arouse animals receiving general anesthesia with either isoflurane or propofol. In the August issue of Anesthesiology, investigators from Massachusetts General Hospital (MGH) report that rats anesthetized with continuous doses of either agent would move, raise their heads and even stand up in response to electrical stimulation delivered to the ventral tegmental area (VTA). Stimulation of the other major dopamine-releasing area, the substantia nigra, did not induce the animals to wake up.
"Dopamine ...
Study suggests disruptive effects of anesthesia on brain cell connections are temporary
2014-07-28
A study of juvenile rat brain cells suggests that the effects of a commonly used anesthetic drug on the connections between brain cells are temporary.
The study, published in this week's issue of the journal PLOS ONE, was conducted by biologists at the University of California, San Diego and Weill Cornell Medical College in New York in response to concerns, arising from multiple studies on humans over the past decade, that exposing children to general anesthetics may increase their susceptibility to long-term cognitive and behavioral deficits, such as learning disabilities.
An ...
UTSW cancer researchers identify irreversible inhibitor for KRAS gene mutation
2014-07-28
DALLAS – July 28, 2014 – UT Southwestern Medical Center cancer researchers have found a molecule that selectively and irreversibly interferes with the activity of a mutated cancer gene common in 30 percent of tumors.
The molecule, SML-8-73-1 (SML), interferes with the KRAS gene, or Kirsten rat sarcoma viral oncogene homolog. The gene produces proteins called K-Ras that influence when cells divide. Mutations in K-Ras can result in normal cells dividing uncontrollably and turning cancerous. These mutations are particularly found in cancers of the lung, pancreas, and colon. ...
Stress-tolerant tomato relative sequenced
2014-07-28
The genome of Solanum pennellii, a wild relative of the domestic tomato, has been published by an international group of researchers including the labs headed by Professors Neelima Sinha and Julin Maloof at the UC Davis Department of Plant Biology. The new genome information may help breeders produce tastier, more stress-tolerant tomatoes.
The work, published July 27 in the journal Nature Genetics, was lead by Björn Usadel and colleagues at Aachen University in Germany. The UC Davis labs carried out work on the transcriptome of S. pennellii — the RNA molecules that are ...
Researchers discover cool-burning flames in space, could lead to better engines on earth
2014-07-28
A team of international researchers has discovered a new type of cool burning flames that could lead to cleaner, more efficient engines for cars. The discovery was made during a series of experiments on the International Space Station by a team led by Forman Williams, a professor of mechanical and aerospace engineering at the University of California, San Diego. Researchers detailed their findings recently in the journal Microgravity Science and Technology.
"We observed something that we didn't think could exist," Williams said.
A better understanding of the cool flames' ...
HIV research findings made possible by a test developed at CU School of Pharmacy
2014-07-28
HIV research findings made possible by a test developed at University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences (CU School of Pharmacy)
AURORA, Colo (July 28, 2014) An influential new test, discovered and developed in the Colorado Antiviral Pharmacology Laboratory at the CU School of Pharmacy, helps monitor the effectiveness of the HIV prevention drug called Truvada (a combination of tenofovir/emtricitabine), which is taken once daily to prevent HIV infection.
A study presented during the AIDS 2014 Conference and published in Lancet Infectious ...
NASA sees Tropical Storm Hernan near Mexico's Baja California
2014-07-28
Tropical Storm Hernan developed over this past weekend and reached hurricane strength before vertical wind shear kicked in and kicked the storm down. NASA's Terra satellite passed over Hernan when it was developing as a tropical depression near Baja California, Mexico.
Tropical Storm Hernan was born on Saturday, July 26 at 5 a.m. EDT as Tropical Depression 8-E. By 5 p.m. EDT it strengthened into Tropical Storm Hernan. At 11 a.m. EDT on Sunday, July 27, Hernan's maximum sustained winds were already up to 70 mph, just four miles per hour shy of hurricane status. As Hernan ...